Anzeigenschluss: 24.01.2025
Erscheinungstermin: 07.02.2025
Top-Thema
Wirtschaft und Gesundheit
Schwerpunkt: Das maligne Melanom - Aktuelles und neue Strategien
mRNA-Impfung
Weber JS et al.
Individualised neoantigen therapy mRNA-4157 (V940) plus pembrolizumab versus pembrolizumab monotherapy in resected melanoma (KEYNOTE-942): a randomised, phase 2b study
CAR-T-Zell-Herstellung und Therapie
Aleksandrova K et al.
Automated manufacturing and characterization of clinical grade autologous CD20 CAR T cells for the treatment of patients with stage III/IV melanoma
Kryoaplation plus Immuntherapie
Mooradian MJ et al.
Cryoablation and post-progression immune checkpoint inhibition in metastatic melanoma: a phase II trial
TLR9-Agonist plus Anti-PD-1-Hemmer in der Neoadjuvanz
Davar D et al.
Neoadjuvant vidutolimod and nivolumab in high-risk resectable melanoma: A prospective phase II trial
Kombination von Anti-PD-1-Hemmer und TIL
L'Orphelin JM et al.
NIVO-TIL: combination anti-PD-1 therapy and adoptive T-cell transfer in untreated metastatic melanoma: an exploratory open-label phase I trial
Medizin
Hämatologie
Morice PM et al.
Acute lymphoblastic leukemia in patients treated with lenalidomide for multiple myeloma: a safety meta-analysis of randomized controlled trials combined with a retrospective study of the WHO’s pharmacovigilance database
Magenkrebs
Leong T et al.
Preoperative Chemoradiotherapy for Resectable Gastric Cancer
Pankreaskarzinom
Mastrantoni L et al.
Comparison of first-line chemotherapy regimens in unresectable locally advanced or metastatic pancreatic cancer: a systematic review and Bayesian network meta-analysis
NSCLC
Lu S et al.
Osimertinib after Chemoradiotherapy in Stage III EGFR-Mutated NSCLC
Brustkrebs
EBCTCG Early Breast Cancer Trialists' Collaborative Group. Reductions in recurrence in women with early breast cancer entering clinical trials between 1990 and 2009: a pooled analysis of 155 746 women in 151 trials
Brustkrebs
Montagna G et al.
Nodal Burden and Oncologic Outcomes in Patients With Residual Isolated Tumor Cells After Neoadjuvant Chemotherapy (ypN0i+): The OPBC-05/ICARO Study
Ovarialkarzinom
Classe JM et al.
Hyperthermic intraperitoneal chemotherapy for recurrent ovarian cancer (CHIPOR): a randomised, open-label, phase 3 trial
Prostatakarzinom
Daskivich TJ et al.
Overtreatment of Prostate Cancer Among Men With Limited Longevity in the Active Surveillance Era
Prostatakarzinom
Li M et al.
Serum glycosylated hemoglobin and prostate cancer risk: Results from a systematic review and dose-response meta-analysis
Nierenzellkarzinom
Kolanukuduru KP et al.
Preoperative Computed Tomography Imaging Accurately Identifies Adrenal Gland Involvement In Patients With Renal Masses
Supportivtherapie
Stone PC et al.
Methylphenidate Versus Placebo for Treating Fatigue in Patients With Advanced Cancer: Randomized, Double-Blind, Multicenter, Placebo-Controlled Trial
Allgemeine Onkologie
Matsuo K et al.
Suicide Deaths Among Adolescent and Young Adult Patients With Cancer
Kongressbericht 1: ASH 2024
Highlights vom 66rd American Society of Hemathology Annual Meeting in San Diego CA/USA,
vom 7.12.–10.12.2024
Kongressbericht 2: SABCS 2024
Highlights vom San Antonio Breast Cancer Symposium in San Antonio, TX/USA, vom
10.12.–14.12.2024
*Die Redaktion behält sich aktuelle Änderungen vor.